The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis by Ido Ben-Shalom, Arnon Karni, Hadar Kolb

Get full text

Characterization of patients with ocular myasthenia gravis — A case series by Arnon Karni, Ali Asmail, Vivian E. Drory, Hadar Kolb, Anat Kesler

Get full text

From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions by Hadar Kolb, Omar Al-Louzi, Erin S. Beck, Pascal Sati, Martina Absinta, Daniel S. Reich

Get full text

Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study by Arnon Karni, Gil Ben Noon, Tamara Shiner, Ifat Vigiser, Hadar Kolb, Keren Regev

Get full text

Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation by Maya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, Moshe Benhamou, Ifat Vigiser, Keren Regev, Hadar Kolb, Arnon Karni

Get full text

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses by Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, Arnon Karni, Mark A. Hellmann, Erez Bar-Haim, Ariel Miller, The Israeli Neuroimmunology Study Group on COVID-19 Vaccination in Multiple Sclerosis, Lea Glass-Marmor, Anat Volkovitz, Sara Dishon, Zeev Dishon, Netta Kugelman, Zeev Nitsan, Marwan Alkrenawi, Nurit Hovel, Nir Michal, Vered Loew-Shavit, Lital Mizrahi, Marsel Zafrani, Panayiota Petrou, Nour Eddine-Yaghmour, Ariel Ginzberg, Ibrahim Kassis, Michelle Halimi, Keren Regev, Hadar Kolb, Ifat Vigiser, Yoav Piora, Irina Komarov, Avigail Hindi, Adi Wilf-Yarkoni, Itay Lotan, Elia Uri, Shaher Rotem, Hila Cohen

Get full text